COX2 Inhibitors As Anti-Cancer Agents The COX2 (Cyclo-Oxygenase) pathway is upregulated in cancer, and COX2 inhibitors (celecoxib) can inhibit cell proliferation, tumor invasiveness, and angiogenesis. They can also overcome apoptosis resistance by BCL2, and overcome P-glycoprotein/MDR drug resistance, as well … Continue reading →
Dipyridamole Anti-Platelet and Anti-Cancer Drug Errors in Oncology-Ignoring the Role of Platelets Platelets are the little sticky cells in our blood that form clots to stop bleeding. This is a good thing. However, it is not a good thing when … Continue reading →
Salicinium Non-Toxic Anti-Cancer Agent by Jeffrey Dach MD A few recent articles in Townsend Letter for Doctors discuss Salicinium as a non-toxic anticancer agent.(1-2) Salicinium was patented in 2011 by Joe Brown as a glyco-benzaldehyde, by adding glucose to benzaldehyde.(19) … Continue reading →
Metformin Repurposed Anti-Cancer Drug Metformin, FDA approved in 1994, is known as “the Good Anti-Diabetic Drug” , taken by 150 million people worldwide for control of blood sugar in Type Two Diabetes.(57) Remarkably, metformin is also an anti-cancer drug. In … Continue reading →
Cancer Immune System Evasion with Progesterone-Induced Blocking Factor In part one of this series, we discussed strategies to eradicate cancer stem cells using Doxycycline and high dose Vitamin C. Unfortunately, a few cancer stem cells, however small in number, will … Continue reading →
Doxycycline Vitamin C Anti-Cancer Synergy Eradicates Cancer Stem Cells I was simply astounded by a publication appearing last week in Oncotarget on anti-cancer synergy of Doxycyline and vitamin C.(1) This is a really huge breakthrough in cancer research, in our … Continue reading →
Intravenous Vitamin C as Cancer Chemotherapy by Jeffrey Dach MD Susan is a new patient who wants hormone replacement for relief of menopausal symptoms. While chatting during her first visit, Susan mentioned that her OB/Gyne doctor has been following her … Continue reading →
You must be logged in to post a comment.